Upload
others
View
7
Download
0
Embed Size (px)
Citation preview
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 1
#POMAD8#ChoosePOMA
Benign and Malignant Epithelial Oral Pathology
Edward J. Halusic, DMD
Diplomate, American Board of Oral and Maxillofacial Surgery
Private Practice, Greensburg, Pa.
POMA District VIII 32nd Annual Educational Winter SeminarSunday, February 3, 2019
Nemacolin Woodlands
#POMAD8#ChoosePOMA
Disclosures
None
#POMAD8#ChoosePOMA
Course Objectives
Upon Completion of the course, participants will be familiar with:
Differential diagnosis of some common reactive processes and soft tissue lesions in the oral cavity
Management strategies for these lesions
1
2
3
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 2
#POMAD8#ChoosePOMA
Outline
Epithelial Pathology
Normal anatomic variants
Inflammatory
Infectious
Reactive/Traumatic
Premalignant
Malignant
#POMAD8#ChoosePOMA
Geographic TongueBenign Migratory Glossitis
Erythema Migrans
• Harmless Condition
• Well defined, reddened areas on the dorsal and lateral tongue with slightly white or yellow-white, raised lines around the edges
• Condition usually waxes ad wanes in severity persisting for a period of time (days to weeks to months)
• Process repeats itself in a different area or areas after a few more days, weeks or months
• When the condition is “active”, the tongue is often sensitive and can feel like it has been scalded to hot, spicy, or acidic foods.
#POMAD8#ChoosePOMA
Burning Mouth Syndrome
• Chronic Pain Condition
• Intraoral burning recurring for more than 2 hours per day for more than 3 months without clinically evident causative lesions
• Women 7:1.
• Usually perimenopausal or menopausal age group.
• 0.7 to 15 % of the population
• Anterior two thirds of the tongue
• Taste alterations
• Oral Dryness
5
6
7
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 3
#POMAD8#ChoosePOMA
Burning Mouth Syndrome
• Complex disease without a clear etiology
• Not well understood or well managed by medicine or dentistry
• Neuropathic.
• Gustatory
• Primary BMS: No local or systemic causes can be identified
• Secondary BMS: Local or systemic caused can be identified
• Prognosis is poor. Spontaneous remission in only about 3% of patients in 5 years.
#POMAD8#ChoosePOMA
Burning Mouth Syndrome Symptoms
• Burning of Oral Mucosa
• Alteration in taste such as bitter or metallic tastes
• Oral Dryness (Xerostomia) in spite of normal salivary flow
• Roughness, sandiness texture
• All of these symptoms can significantly affect quality of life
#POMAD8#ChoosePOMA
Burning Mouth Syndrome Diagnosis
Fungal Infections
Mechanical Trauma
Thermal Trauma
Chemical Injury
Xerostomia
Parafunctional Habits
Oral Pathology
Allergic Contact Stomatitis
Must rule out Secondary BMS
8
9
10
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 4
#POMAD8#ChoosePOMA
Burning Mouth Syndrome DiagnosisSubstance List for Allergic
Contact StomatitisChemicals Where found
Zinc, Cobalt, Mercury, Gold, Palladium Dental Materials
Nickel Sulfate Dental Materials, Stainless Steel, Food (e.g., shrimp and chocolate milk)
Sodium Lauryl Sulfate Toothpaste
Fragrance Mix Oral Care Products
Balsam of Peru Oral Care Products, Citrus Fruits, Spices, Cough Medicines and Lozenges
Cinnamic Alcohol Cinnamon and products with cinnamon flavor
Nasri-Heir et al, J Indian Prosthodontic Society, 2015 Oct-Dec; 15)4): 300-307
#POMAD8#ChoosePOMA
Burning Mouth Syndrome Diagnosis
Endocrine Disorders
Immunological Disorders (Sjogren’s)
GERD
Must rule out Secondary BMS
#POMAD8#ChoosePOMA
Burning Mouth Syndrome Diagnosis
Basic Metabolic Panel
Iron Serum levels/ferritin
Vitamin B12 and folate levels to rule out associated anemias
ANA, Anti/SS-A, Anti/SS-B, Rheumatoid Factor to rule out Sjogren’s
CBC
Cytological smears if candidiasis is suspected
Salivary Flow Rates if xerostomia is suspected
Skin Patch Tests if allergic reactions are suspected
Must rule out Secondary BMS
11
12
13
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 5
#POMAD8#ChoosePOMA
Burning Mouth Syndrome Diagnosis
Medications (Augment/Induce Burning(ACE), Xerostomia)
Must rule out Secondary BMS
#POMAD8#ChoosePOMA
Medications related to Hyposalivation/Xerostomia
Nasri-Heir et al, J Indian Prosthodontic Society, 2015 Oct-Dec; 15)4): 300-307
Medications Examples
Tricyclic Antidepressants Amitriptyline, nortriptyline
Antipsychotic Carbidopa/levodopa,chlorpromazine
Antihistaminic Phenergan
Bronchodilator (anticholinergic and B-2 agonist)
Tiotropium, formoterol
Decongestant Oxymetazoline
Antidepressant Venlafaxine
Skeletal muscle relaxant Tizanidine
Antihypertensives Furosemide, clonidine, lisinopril, verapamil
Chemotherapy Cyclophosamide
Protease inhibitor for HIV Reyataz, Norvir, Kaletra
Opioid Hydrocodone, oxycodone
Benzodiazepine Diazepam
#POMAD8#ChoosePOMA
Treatment of Burning Mouth Syndrome
Nasri-Heir et al, J Indian Prosthodontic Society, 2015 Oct-Dec; 15)4): 300-307
Benzodiazepenes:
• Clonazepam. GABA agonist.
• 70% reduction in pain levels with oral dose of 0.5-1.5 mg/day to maximum of 3 mg. (Grushka et al.)
• Significant reduction in pain at dose of 0.5 mg/day after 9 weeks of treatment when compared to control group. (Heckman et al.)
14
15
16
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 6
#POMAD8#ChoosePOMA
Treatment of Burning Mouth Syndrome
Nasri-Heir et al, J Indian Prosthodontic Society, 2015 Oct-Dec; 15)4): 300-307
Anticonvulsants such as gabapentin at 300 mg/day showed some favorable results in one study which could not be confirmed in another study.
Tricyclic antidepressants at 10-40 mg/day have shown to be beneficial in relieving pain although side effect of xerostomia may be unfavorable.
SSRI’s: Paroxetine with initial dose of 10-20 mg/day to maximum of 30 mg/day revealed 80% of patients experienced pain reduction with 12 weeks.
Serotonin noradrenaline reuptake inhibitors: significant decrease in pain levels after 12 weeks of treatment with minalcipran 15 mg/day to 100 mg/day.
Histamine H2 receptor antagonist: significant improvement in pain levels using lafutidine(India) 10 mg twice daily for 12 weeks. It has a sensitive effect on capsaicin-sensitive afferent neurons improvement in pain levels using lafutidine 10 mg twice daily for 12 weeks. In US, equivalent would be famotidine or ranitidine.
#POMAD8#ChoosePOMA
Treatment of Burning Mouth Syndrome
Nasri-Heir et al, J Indian Prosthodontic Society, 2015 Oct-Dec; 15)4): 300-307
Alpha Lipoic Acid: Potent antioxidant. One study showed efficacy while another did not confirm the results.
Topical: Capsaicin. Hot component of chili peppers.
Topical Treatment: Clonazepam. 1.0 mg dissolved. 3 times per day. Hold for 3 minutes and expectorate. 66% of patients reported resolution of symptoms and 29% reported partial reduction of symptoms after 6 months.
Psychologic/Psychiatric Intervention: Individual or small group cognitive-behavior therapy has been shown to reduce the intensity of the pain of BMS. Some authors feel this is a critical component of treating patients with BMS as 50% of patients presented with psychiatric disorders including anxiety, depression, obsessive or psychosomatic symptoms.
#POMAD8#ChoosePOMA
Treatment of Burning Mouth Syndrome
Nasri-Heir et al, J Indian Prosthodontic Society, 2015 Oct-Dec; 15)4): 300-307
• Foods that cause burning or exacerbate symptoms should be avoided. ( Pineapple, tomato orange, lemon,etc.)
• Smoking, alcohol, and mouth rinses with alcohol should be avoided
• Toothpastes with abrasive substances should be avoided.
17
18
19
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 7
#POMAD8#ChoosePOMA
Lichen PlanusCommon chronic mucocutaneousautoimmune mediated disease– 1.27% prevalence
• Most common in women 30‐60 yrs– 3:2 to female to male
• Associated with cell‐mediated immunologicdysfunction
Erosive
Skin Lesions • 4P’s- Purple- Pruritic- Polygonal- Papules
- Most commonly seen on the flexor surfaces
Reticular
#POMAD8#ChoosePOMA
Lichen Planus TreatmentTopical SteroidsSystemic SteroidsSystemic Steroid Sparing Agents (Calcineurin Inhibitors)
-Tacrolimnus (topical)
-Cyclosporine (topical)
Erosive
Skin Lesions • 4P’s- Purple- Pruritic- Polygonal- Papules
- Most commonly seen on the flexor surfaces
Reticular
#POMAD8#ChoosePOMA
Lichen Planus Treatment
Topical Steroids
Lidex Gel (Fluocinonide) 0.05%• Disp: 30 g tube• Coat the lesion with a thin film after
each meal and at bedtime
* Can be compounded with Orabase(methylcellulose base)
Dexamethasone Elixir (.5mg/ml)
• Disp: 250cc• Sig: Rinse with 1 teaspoon (5ml) 4
times a day and spit
• Do not eat or drink for 30 minutes after using the elixir
• Advantages- covers large area of oral cavity
20
21
22
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 8
#POMAD8#ChoosePOMA
Lichen Planus Treatment
Calcineurin Inhibitor
Tacrolimus 0.1%• Disp: 30 g tube• Sig: Apply to affected site twice daily
#POMAD8#ChoosePOMA
Lichen Planus Treatment
Systemic Steroids
Prednisone• 8 week regimen. 10 mg. x 105 tablets. • 20 mg four times per day every other day for two
weeks.• 20 mg twice per day every other day for two weeks.• 20 mg once per day every other day for two week.• 10 mg once per day every other day for two weeks.
Medrol Dose Pack• Disp: One pack• Sig: Use as directed
#POMAD8#ChoosePOMA
• Susceptibility to infection- Oral candidiasis
• Insomnia- Dose oral steroids in the morning
• Hyperglycemia• Poor wound healing• Capillary fragility• Hypertension• Glaucoma• Adrenal suppression• Mood swings• Peptic ulceration
- Care with ASA/NSAIDS, consider PPI
• Cushing syndrome
Complications of Steroid Therapy
23
24
25
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 9
#POMAD8#ChoosePOMA
• Reported 0.04 to 1.74% of oral lichen planus has malignant transformation to squamous cell carcinoma
- Mainly erosive & atrophic forms, poorly controlled
• Must see classic LP i.e. bilateral, symmetric, reticulated, at the usual sites
• Repeat biopsy if change in the character of the lesions
Squamous cell carcinoma arising in Lichen Planus
#POMAD8#ChoosePOMA
Differential Diagnoses
• Lichenoid Drug Reaction
• Lichenoid Contact Stomatitis
• Chronic Ulcerative Stomatitis
• Vesiculobullous disease
• Lupus Erythematosus
Case
• 54 year old female presents with a 13 month history of “oral sores”
• She has seen numerous providers- Past diagnoses and treatment include: shingles,
thrush, and herpes• PMHx: Hx MI, Hx pericardial effusion, gout• Meds: Aspirin, Carvedilol, Citalopram, Furosemide,
Docusate Sodium, Eliquis, Atorvastatin, Allopurinol, Albuterol, Maalox, Ambien, Magic Swizzle, Zofran (prn)
#POMAD8#ChoosePOMA
Differential Diagnoses
• Lichenoid Drug Reaction
• Lichenoid Contact Stomatitis
• Chronic Ulcerative Stomatitis
• Vesiculobullous disease
• Lupus Erythematosusallopurinol
Case
• 54 year old female presents with a 13 month history of “oral sores”
• She has seen numerous providers- Past diagnoses and treatment include: shingles,
thrush, and herpes• PMHx: Hx MI, Hx pericardial effusion, gout• Meds: Aspirin, Carvedilol, Citalopram, Furosemide,
Docusate Sodium, Eliquis, Atorvastatin, Allopurinol, Albuterol, Maalox, Ambien, Magic Swizzle, Zofran (prn)
26
27
28
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 10
#POMAD8#ChoosePOMA
Differential Diagnoses
• Lichenoid Drug Reaction
• Lichenoid Contact Stomatitis
• Chronic Ulcerative Stomatitis
• Vesiculobullous disease
• Lupus Erythematosus
Medications associated with lichenoid reactions
- Antihypertension agents- Diurectics (e.g. HCTZ), beta blockers, ACE
inhibitors- Sulfonylureas- Levothyroxine- Sulfasalazine- Allopurinol- NSAIDs- Carbamazepine- Some statins- Biologics such as TNF alpha inhibitor
#POMAD8#ChoosePOMA
Differential Diagnoses
• Lichenoid Drug Reaction
• Lichenoid Contact Stomatitis
• Chronic Ulcerative Stomatitis
• Vesiculobullous disease
• Lupus Erythematosus
Lichenoid Reaction to Gold
#POMAD8#ChoosePOMA
New Case
• 66 yo female presents with CC of “my gums hurt bad”• PMHx: Hypertension, thyroid disease, and arthritis
• She is being worked up for autoimmune disease • Arthritis vs connective tissue disorder
associated with a rash on her chest and arms for years
• Meds: Prednisone 5 mg/day, Citalopram, Bupropion, Lisonopril, Levothyroxine, Methotrexate, Folic Acid, and Vitamin C, B12 injections
Exam
• Posterior left lateral border of the tongue, there is a 1cm ulcer
• Maxillary left alveolar crestal mucosa tooth area 13: There is erythema and a 0.3 cm small ulceration
• Right mandibular alveolar crest, #30 area: ulcer with a pseudomembrane 0.5 to 0.7 cm
29
30
31
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 11
#POMAD8#ChoosePOMA
Biopsy of tongue: Ulcer and Epithelial Dysplasia
#POMAD8#ChoosePOMA
Methotrexate
New Case
• 66 yo female presents with CC of “my gums hurt bad”• PmHx: Hypertension, thyroid disease, and arthritis
• She is being worked up for autoimmune disease • Arthritis vs connective tissue disorder
associated with a rash on her chest and arms for years
• Meds: Prednisone 5 mg/day, Citalopram, Bupropion, Lisonopril, Levothyroxine, Methotrexate, Folic Acid, and Vitamin C, B12 injections
#POMAD8#ChoosePOMA
Potential etiologies for oral ulceration
• Trauma• Factitious
• Chemical• Idiopathic
• Recurrent Aphthous Stomatitis• Medication-Related Ulceration• Infectious Ulceration
• Viral• Herpes simplex virus• Varicella zoster (Shingles)• Epstein-Barr virus
• Fungal
• Mucocutaneous Disease• Lichen planus• Erythema Multiforme• Benign mucous membrane pemphigoid• Pemphigus vulgaris
• Autoimmune/Systemic Diseases• Celiac disease• Crohn’s • Bechet’s disease• Lupus erythematous
32
33
34
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 12
#POMAD8#ChoosePOMA
Clinical History
• Patient Presents with non-healing ulcer of several weeks duration
• CC: “My tongue hurts”
• History reveals patient was biting his tongue during the night and was waking up in pain. Ulcer seem to be secondary to repetitive trauma.
• Dx: Nocturnal Tongue Biting
• Rx: Occlusal Night Guard to protect tongue from trauma of biting.
Pre Occlusal GuardPre Occlusal Guard
Post Occlusal Guard
#POMAD8#ChoosePOMA
#POMAD8#ChoosePOMA
Aphthous Ulcers
• 10-20% of the general population• 40+% of college-age pop during exams• Idiopathic• Immune dysregulation• Tan-gray surface coat with fiery red-halo• Origin on loose, NON-keratinized mucosa• Unlikely to develop AFTER ~40yrs
3 Forms
• Minor• 80%, 4-6mm diameter, round to oval, 7-
10 day duration• Major
• More rare, >1 cm, irregular outline, 4-6 week duration, heals with scaring
• Clusterform• Punctate 2-3 mm, 10-100 lesions, • Extend onto keratinized tissue
#POMAD8#ChoosePOMA
Clinician’s Guide Treatment of Common Oral Lesions. Siegel, Silverman, and Collection 6th Ed. BC Decker.
MBX for palliative treatment.
Equal part of:- 2% Viscous Xylocaine- Maalox-Benadryl Elixir (2.5 mg/ml)
Treatment-Aphthous Ulcers
• Rx: Triamcinolone acetonide (Kenalog) in Orabase 0.1%Disp: 5gm tubeSig: Apply to affected area t.i.d. for no more than 2 weeks(DO NOT RUB IN)
• Rx: Dexamethasone elixir (0.5mg/5ml)Disp:200ccSig: Swish with 1 tsp for 2 min then spit out, q.i.d.
Treatment is usually only for major or multiple, symptomatic aphthae.
Do no eat or brush 30 minutes after application.
35
36
37
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 13
#POMAD8#ChoosePOMA
• Aphthous stomatitis
• No vesicles• Begins as an ulcer• Disproportionate pain• Loose, non-keratinized
mucosa• Round, oval red halo
• Herpes stomatitis
• Mult. Small vesicles• Merge to form ulcers• Painful• Keratinized mucosa• Irrregular
#POMAD8#ChoosePOMA
Herpes Simplex Virus
• Retrograde travels to sensory ganglia• Virus remains dormant in
ganglia until reactivation • Viral latency• Recurrence is heralded by itching,
tingling, burning sensation• Virus then travels down
sensory nerve • Reinfecting epithelium
• Fragile vesicles form in clusters on keratinized epithelium
• Scratching vesicles can lead to autoinoculation of other sites
#POMAD8#ChoosePOMA
Treatment – Recurrent HSV
• Rx: Docansol (Abreva) cream (OTC)Disp: 2gm tubeDab on lesion 5 times daily during waking hours, for 4 days beginning when symptoms first appear. (NOT for use intraorally. On lips only.)
• Rx: Valacyclovir (Valtrex) caplets 500 mg Disp: 8 capsTake 4 caps as soon as prodromal symptoms are recognized and then 4 caps twelve hours later
• Lysine 1000 mg; 500 mg twice per day.
38
39
40
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 14
#POMAD8#ChoosePOMA
Suggested Drug Therapies for Oral Candidiasis
Rx: Mycelex (clotrimazole) troches 10mg or Nystatin pastilles• Disp: 70 troches (or pastilles)• Sig: 1 troche (or pastille) dissolved slowly in mouth 5 times a
day for 14 days
Rx: Fluconazole (Diflucan) tablets 100mg • Disp.: 15 tabs• Sig: Take 2 tabs stat, then 1 tablet daily until gone
Patients with denture stomatitis (with candidiasis)Rx: Nystatin ointment• Disp: 30 gram tube • Sig: Apply to denture base and insert denture t.i.d. (Note: The patient should also be instructed to clean denture and soak. If the patient wears a partial denture with metal connectors, avoid bleach solutions– Use OTC soaking product or Nystatin suspension)
Clinician’s Guide Treatment of Common Oral Lesions . Siegel, Silverman, & Sollecito. 6th Ed. BC
#POMAD8#ChoosePOMA
Squamous Papilloma
• Caused by HPV 2, 6, 11, 57 (low risk types)• Immunosuppressed patients at a higher risk• Painless exophytic pedunculated or sessile masses
with a cauliflower-like surface• Most frequent sites: soft palate, tongue, lip• Less than 0.5 cm in diameter• Differential: Verruca, condyloma, Heck’s• Treatment: Surgical excision
#POMAD8#ChoosePOMA
• Patient presents with an exophytic white lesion lower lip
• Previous excision in 2008Verruca Vulgaris (common wart)
• HPV 2, 4, 6, 40 (low risk types)• Can spread by autoinoculation• Most common in children• Most frequent intraoral sites are lip, labial
mucosa, and anterior tongue • Single or multiple, white, pedunculated or
sessile, papillary or pebbly lesion(s)
Treatment• Excision• CO2 Laser: High rate of efficacy
41
42
43
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 15
#POMAD8#ChoosePOMA
#POMAD8#ChoosePOMA
Diagnosis
• Papillary keratosis• Mild epithelial dysplasia
• PVL? Proliferative Veruccous Leukoplakia
Clinical History- 74 yo female
• Patient presents with a rough white patch of the maxillary molar area (#2-3) of 3 years duration.
• A smaller patch is present on the contralateral side in the area of #13-14.
• PMHx: Hypothyroidism, Hx rheumatic fever• SH: 1/2ppd (15 pack years)• Ddx: Hyperkeratosis, verrucous carcinoma
#POMAD8#ChoosePOMA
Case History
• 71 yo female• Greater than 1 year history of multiple tongue lesions.• “Fibrotic tissue at the lateral border of the tongue and
papillary growths present adjacent to the fibrotic tissue.”
• PMHx-hypertension, osteoporosis, hyperlipidemia and Sjogren’s syndrome.
• Previous pathology report from the right buccal mucosa interpreted as a benign squamous papilloma from an outside institution.
Verrucous CA Papillary keratosis with dysplasia
44
45
46
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 16
#POMAD8#ChoosePOMA
Proliferative Verrucous Leukoplakia:
• Condition characterized by the development of multiple, persistent, leukoplakias
• Not associated with tobacco use• Many will develop a verrucous carcinoma
and/or a squamous cell carcinoma• Long term follow-up warranted
MAJOR CRITERIA MINOR CRITERIA
A. A leukoplakic lesion with more than two different oral sites.B. The existence of a verrucousarea.C. The lesions have spread or enlarged during developmentof the disease.D. There has been a recurrence in a previously-treated area.E. Histopathologically, there can be from keratosis to verrucous hyperplasia,verrucous carcinoma or OSCC, whetherin situ or infiltrating.
A. An oral leukoplakic lesion that occupies at least 3 cfm when adding all the affected areas.B. The patient is a female. C. The patient (male or female) is a non-smoker. D. A disease evolution higher than 5 years.
In order to make the diagnosis of PVL, it was suggested that one of the two following combinations of the criteria mentioned before were met,
1. Three major criteria (Criterion E must be fulfilled) or 2. Two major criteria (Criterion E must be fulfilled) + two minor criteria.
#POMAD8#ChoosePOMA
History
• 59 year old male • Social Hx: -Tobacco, ETOH Socially• Irregular dental care intervals• Previousy Biopsies 4 & 2 yrs ago• Lesion is spreading to adjacent teeth• Previous Pathology: Focal keratosis
#POMAD8#ChoosePOMA
Malignant Epithelial Pathology
47
48
49
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 17
#POMAD8#ChoosePOMA
Clinical History
• 66 yo male with history of SSC R neck 10 years ago treated with chemoradiation
• Now with induration of the left alveolar ridge under denture and with rapid growth
#POMAD8#ChoosePOMA
Verrucous carcinoma
Treatment and prognosis• Surgical excision without neck dissection• Very low change of metastasis• Recurrence depends on ability to excise• 90% disease-free after 5 years
Verrucous carcinoma- Clinical features
• Low-grade variant of SC• Mostly men >55 years old (appears a decade sooner
than regular SCC)• Usually large lesion when diagnosed• Painless, slow-growing• Papillary or verrucous surface• Usually white in color, depending on amount of
keratin• Mary arise in proliferative verrucous leukoplakia
(PVL)
Verrucous carcinoma
#POMAD8#ChoosePOMA
A word about bisphosphonates…..
Complete Dental Exam
50
51
52
“Benign and Malignant Epithelial Oral Pathology”Edward Halusic, Jr., DMD
POMA District VIII 32nd Annual Educational Winter SeminarJanuary 31-February 3, 2019 18
#POMAD8#ChoosePOMA
Thank you!!
53